These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 33962640)
1. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma. Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640 [TBL] [Abstract][Full Text] [Related]
2. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Long M; Zhou Z; Wei X; Lin Q; Qiu M; Zhou Y; Chen P; Jiang Y; Wen Q; Liu Y; Li R; Zhou X; Yu H Front Immunol; 2022; 13():1023349. PubMed ID: 36353638 [TBL] [Abstract][Full Text] [Related]
3. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma. Dai K; Liu C; Guan G; Cai J; Wu L BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781 [TBL] [Abstract][Full Text] [Related]
4. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes]. Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028 [No Abstract] [Full Text] [Related]
5. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma. Wang L; Wang L; He P Front Genet; 2022; 13():1064432. PubMed ID: 36568383 [No Abstract] [Full Text] [Related]
6. Exploring potential targets of Actinidia chinensis Planch root against hepatocellular carcinoma based on network pharmacology and molecular docking and development and verification of immune-associated prognosis features for hepatocellular carcinoma. Qu M; Han T; Chen X; Sun Q; Li Q; Zhao M J Gastrointest Oncol; 2022 Jun; 13(3):1289-1307. PubMed ID: 35837167 [TBL] [Abstract][Full Text] [Related]
7. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma. Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167 [TBL] [Abstract][Full Text] [Related]
8. Identification and Analysis of Immune-Related Gene Signature in Hepatocellular Carcinoma. Shen B; Zhang G; Liu Y; Wang J; Jiang J Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292719 [TBL] [Abstract][Full Text] [Related]
9. A New Risk Score Based on Eight Hepatocellular Carcinoma- Immune Gene Expression Can Predict the Prognosis of the Patients. Ye D; Liu Y; Li G; Sun B; Peng J; Xu Q Front Oncol; 2021; 11():766072. PubMed ID: 34868990 [TBL] [Abstract][Full Text] [Related]
10. A novel prognostic index of hepatocellular carcinoma based on immunogenomic landscape analysis. Xiao H; Wang B; Xiong HX; Guan JF; Wang J; Tan T; Lin K; Zou SB; Hu ZG; Wang K J Cell Physiol; 2021 Apr; 236(4):2572-2591. PubMed ID: 32853412 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
12. A New Inflammation-Related Risk Model for Predicting Hepatocellular Carcinoma Prognosis. Xing M; Li J Biomed Res Int; 2022; 2022():5396128. PubMed ID: 35572724 [TBL] [Abstract][Full Text] [Related]
13. Identifying Dendritic Cell-Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis. Huang C; Jiang X; Huang Y; Zhao L; Li P; Liu F Front Mol Biosci; 2021; 8():636991. PubMed ID: 34109210 [TBL] [Abstract][Full Text] [Related]
14. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma. Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867 [No Abstract] [Full Text] [Related]
15. A novel prognostic model based on immunogenic cell death-related genes for improved risk stratification in hepatocellular carcinoma patients. Liu T; Chen X; Peng B; Liang C; Zhang H; Wang S J Cancer Res Clin Oncol; 2023 Sep; 149(12):10255-10267. PubMed ID: 37269346 [TBL] [Abstract][Full Text] [Related]
16. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [TBL] [Abstract][Full Text] [Related]
17. Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma. Zhu Z; Song M; Li W; Li M; Chen S; Chen B Front Oncol; 2021; 11():695001. PubMed ID: 34616672 [TBL] [Abstract][Full Text] [Related]
18. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients. Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220 [TBL] [Abstract][Full Text] [Related]
19. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer. Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W J Oncol; 2022; 2022():5468858. PubMed ID: 36467500 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma. Wang X; Li Y; Shi Y; Luo J; Zhang Y; Pan Z; Wu F; Tian J; Yu W Front Cell Dev Biol; 2022; 10():887076. PubMed ID: 35990607 [No Abstract] [Full Text] [Related] [Next] [New Search]